Ravneet Bhullar, MD
Pain Medicine · Slingerlands, NYNPI 1053464503
Payments from drug & device makers
Across 36 payments — averaging $258.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- International Rehabilitative Sciences, Inc$8K
- Boston Scientific$339
- SPR Therapeutics, Inc$272
- Stratus Medical, LLC$193
- Avanos Medical$182
- Medtronic$167
- plus $489 from 4 others
What the payments were for
- Food & beverage$1,70418%
- Other$7,58982%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| International Rehabilitative Sciences, Inc | 3 | $7,652 |
| Boston Scientific | 6 | $339 |
| SPR Therapeutics, Inc | 13 | $272 |
| Stratus Medical, LLC | 1 | $193 |
| Avanos Medical | 3 | $182 |
| Medtronic(2 entities) | 6 | $167 |
| Intrinsic Therapeutics | 1 | $136 |
| Nevro Corp. | 1 | $132 |
| Averitas Pharma Inc. | 1 | $126 |
| Vertex | 1 | $95 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RS 4i Plus Sequential Stimulator$7,589
- RS-LBG, RS-FBG$7,589
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$272
- Nimbus$193
- Omnia$132
- Intracept$132
- Qutenza$126
- SPRINT PNS System$121
- GENERATOR$119
- AUTOFILL$104
How this compares
$9,294 in reported general payments places this provider in the 80th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 191 | $2,724 |
| Pregabalin | 106 | $2,580 |
| Duloxetine Hcl | 57 | $1,218 |
| Tizanidine Hcl | 114 | $1,101 |
| Cyclobenzaprine Hcl | 77 | $615 |
| Celecoxib | 20 | $317 |
| Nortriptyline Hcl | 19 | $239 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $216 |
| Tramadol Hcl | 29 | $141 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Slingerlands
- Gary SchwartzBrooklyn$756K
- Amitabh GulatiNew York$627K
- William CaldwellStony Brook$550K
- Brian DurkinPort Jefferson$459K
- Grace FordeNew Hyde Park$398K
- David SpinnerNew York$391K
- John MarkmanRochester$300K
- Naum ShaparinBronx$178K
- Ashraf HenryAmherst$168K
- Kenneth ChapmanStaten Island$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.